{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:51:56Z","timestamp":1791049916265,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1187,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Hepatocellular carcinoma (HCC) is a particularly lethal form of cancer, yet effective therapeutic options for advanced HCC are limited. The poly(ADP-ribose) polymerases (PARPs) and histone deacetylases (HDACs) are emerging to be among the most promising targets in cancer therapy, and sensitivity to PARP inhibition depends on homologous recombination (HR) deficiency and inhibition of HDAC activity blocks the HR pathway. Here, we tested the hypothesis that cotargeting both enzymatic activities could synergistically inhibit HCC growth and defined the molecular determinants of sensitivity to both enzyme inhibitors. We discovered that HCC cells have differential sensitivity to the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) and PARP inhibitor olaparib, and identified one pair of cell lines, termed SNU-398 and SNU-449, with sensitive versus resistant phenotype to both enzyme inhibitors, respectively. Coadministration of SAHA and olaparib synergistically inhibited the growth of SNU-398 but not SNU-449 cells, which was associated with increased apoptosis and accumulated unrepaired DNA damage. Multiple lines of evidence demonstrate that the hepatic fibrosis\/hepatic stellate cell activation may be an important genetic determinant of cellular sensitivity to both enzymatic inhibitors, and coordinate activation or inactivation of the aryl hydrocarbon receptor (AhR) and cyclic adenosine monophosphate (cAMP)-mediated signaling pathways are involved in cell response to SAHA and olaparib treatment.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>These findings suggest that combination therapy with both enzyme inhibitors may be a strategy for therapy of sensitive HCC cells, and identification of these novel molecular determinants may eventually guide the optimal use of PARP and HDAC inhibitors in the clinic.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.25566","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T06:49:02Z","timestamp":1324968542000},"page":"1840-1851","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":37,"title":["Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases"],"prefix":"10.1097","volume":"55","author":[{"given":"Jun-Xiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwu Ruth","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Motwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Vasiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyanthy","family":"Eswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lopa","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20241201","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrc2812","article-title":"PARP inhibition: PARP1 and beyond.","volume":"10","author":"Rouleau","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R2-22-20241201","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADPribose): novel functions for an old molecule.","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R3-22-20241201","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2deficient tumours with inhibitors of poly(ADPribose) polymerase.","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"R4-22-20241201","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1006\/jmbi.2001.4564","article-title":"DNA doublestrand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells.","volume":"307","author":"Arnaudeau","year":"2001","journal-title":"J Mol Biol"},{"key":"R5-22-20241201","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"R6-22-20241201","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADPribose) polymerase inhibition.","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res"},{"key":"R7-22-20241201","doi-asserted-by":"crossref","first-page":"19482","DOI":"10.1073\/pnas.0707828104","article-title":"HDAC inhibitor PCI24781 decreases RAD51 expression and inhibits homologous recombination.","volume":"104","author":"Adimoolam","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-22-20241201","doi-asserted-by":"crossref","first-page":"e11208","DOI":"10.1371\/journal.pone.0011208","article-title":"Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor.","volume":"5","author":"Kachhap","year":"2010","journal-title":"PLoS One"},{"key":"R9-22-20241201","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00280-010-1344-7","article-title":"Histone deacetylase inhibitor (HDACI) PCI24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells.","volume":"67","author":"Yang","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"R10-22-20241201","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijrobp.2004.12.088","article-title":"Modulation of radiation response by histone deacetylase inhibition.","volume":"62","author":"Chinnaiyan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-22-20241201","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment.","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R12-22-20241201","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.21804","article-title":"Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma.","volume":"46","author":"Lu","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R13-22-20241201","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nsmb.1831","article-title":"53BP1 loss rescues BRCA1 deficiency and is associated with triplenegative and BRCAmutated breast cancers.","volume":"17","author":"Bouwman","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"R14-22-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-1536-2-1","article-title":"Evaluation of intracellular signalling pathways in response to insulinlike growth factor I in apoptoticresistant activated human hepatic stellate cells.","volume":"2","author":"Gentilini","year":"2009","journal-title":"Fibrogenesis Tissue Repair"},{"key":"R15-22-20241201","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2005.082701","article-title":"Overexpression of Bcl2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.","volume":"55","author":"Novo","year":"2006","journal-title":"Gut"},{"key":"R16-22-20241201","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1006\/bbrc.1998.9387","article-title":"Activated rat stellate cells express cmet and respond to hepatocyte growth factor to enhance transforming growth factor beta1 expression and DNA synthesis.","volume":"250","author":"Ikeda","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-22-20241201","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc990","article-title":"The endothelin axis: emerging role in cancer.","volume":"3","author":"Nelson","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R18-22-20241201","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1073\/pnas.93.13.6731","article-title":"Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development.","volume":"93","author":"Schmidt","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-22-20241201","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/mol.104.005223","article-title":"The aryl hydrocarbon receptor predisposes hepatocytes to Fasmediated apoptosis.","volume":"67","author":"Park","year":"2005","journal-title":"Mol Pharmacol"},{"key":"R20-22-20241201","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.freeradbiomed.2010.08.004","article-title":"Molecular characterization, expression analysis, and role of ALDH3B1 in the cellular protection against oxidative stress.","volume":"49","author":"Marchitti","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"R21-22-20241201","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1369\/jhc.2010.955773","article-title":"Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellularspecific localization in normal and cancerous human tissues.","volume":"58","author":"Marchitti","year":"2010","journal-title":"J Histochem Cytochem"},{"key":"R22-22-20241201","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/emboj.2008.61","article-title":"A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor.","volume":"27","author":"Turner","year":"2008","journal-title":"EMBO J"},{"key":"R23-22-20241201","doi-asserted-by":"crossref","first-page":"21920","DOI":"10.1074\/jbc.M803193200","article-title":"Protein kinase A (PKA) isoform RIIbeta mediates the synergistic killing effect of cAMP and glucocorticoid in acute lymphoblastic leukemia cells.","volume":"283","author":"Ji","year":"2008","journal-title":"J Biol Chem"},{"key":"R24-22-20241201","first-page":"821","article-title":"Expression of poly(ADPribose) polymerase in human hepatocellular carcinoma and analysis of biopsy specimens obtained under sonographic guidance.","volume":"12","author":"Shimizu","year":"2004","journal-title":"Oncol Rep"},{"key":"R25-22-20241201","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1440-1746.2001.02378.x","article-title":"Enhanced polyadenosine diphosphateribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma.","volume":"16","author":"Shiobara","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"R26-22-20241201","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hep.23249","article-title":"Inhibition of poly adenosine diphosphateribose polymerase decreases hepatocellular carcinoma growth by modulation of tumorrelated gene expression.","volume":"51","author":"QuilesPerez","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R27-22-20241201","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1158\/0008-5472.CAN-09-4716","article-title":"Poly(ADPribose) polymerase is hyperactivated in homologous recombinationdefective cells.","volume":"70","author":"Gottipati","year":"2010","journal-title":"Cancer Res"},{"key":"R28-22-20241201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2005.37.1.1","article-title":"Biology of SNU cell lines.","volume":"37","author":"Ku","year":"2005","journal-title":"Cancer Res Treat"},{"key":"R29-22-20241201","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7150\/ijbs.2.179","article-title":"The inhibition and treatment of breast cancer with poly (ADPribose) polymerase (PARP1) inhibitors.","volume":"2","author":"De Soto","year":"2006","journal-title":"Int J Biol Sci"},{"key":"R30-22-20241201","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1470-2045(11)70214-5","article-title":"Olaparib in patients with recurrent highgrade serous or poorly differentiated ovarian carcinoma or triplenegative breast cancer: a phase 2, multicentre, openlabel, nonrandomised study.","volume":"12","author":"Gelmon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R31-22-20241201","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-717X-4-69","article-title":"The cMet receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.","volume":"4","author":"Welsh","year":"2009","journal-title":"Radiat Oncol"},{"key":"R32-22-20241201","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.radonc.2009.06.031","article-title":"Receptor signaling as a regulatory mechanism of DNA repair.","volume":"92","author":"Meyn","year":"2009","journal-title":"Radiother Oncol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25566","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201206000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:01:02Z","timestamp":1733061662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201206000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25566","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}